References

  1. World Health Organization. Global tuberculosis report. 2012. http://who.int/tb/publications/global_report/gtbr12_main.pdf. Accessed 30 April 2014.

  2. Pérez-Guzmán C, Vargas MH. Hypocholesterolemia: a major risk factor for developing pulmonary TB. Med Hypotheses. 2006; 66(6):1227–1230. PubMed | Google Scholar

  3. Pérez-Guzmán C, Vargas MH, Qui?onez F, Bazavilvazo N, Aguilar A. A cholesterol-rich diet accelerates bacteriologic sterilization in pulmonary TB. Chest. 2005; 127(2):643–651. PubMed | Google Scholar

  4. Deniz O, Gumus S, Yaman H, Ciftci F, Ors F, Cakir E, Tozkoparan E, Bilgic H, Ekiz K. Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary TB. Clin Biochem. 2007; 40(3-4):162–166. PubMed | Google Scholar

  5. Kim MJ, Wainwright HC, Locketz M, Bekker LG, Walther G, et al. Caseation of Human TB Granulomas Correlates with Elevated Host Lipid Metabolism. EMBO Mol Med. 2010; 2(7):258–274. PubMed | Google Scholar

  6. Drabowsky MP, Peel WE, Thomson AER. Plasma membrane cholesterol regulates human lymphocyte cytotoxic function. Eur J Immunol. 1980; 10(11):821–827. PubMed | Google Scholar

  7. Heiniger HJ, Marshall JD. Cholesterol synthesis in polyclonally activated cytotoxic lymphocytes and its requirements for differentiation and proliferation. Proc Natl Acad Sci. 1982; 79(12):3823–3827. PubMed | Google Scholar

  8. Lü HZ, Zhu AY, Chen Y, Tang J, Li BQ. Formation and aggregation of lipid rafts in δγ Tcells following stimulation with Mycobacterium tuberculosis antigens. J Exp Med. 2011; 233(3):193-198. PubMed | Google Scholar

  9. Ouellet H, Guan S, Johnston JB, Chow ED, Kells PM, et al. Mycobacterium tuberculosis CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest-4-en-3-one. Mol Microbiol. 2010; 77(3):730-742. PubMed | Google Scholar

  10. Ouellet H, Johnston JB, Ortiz de Montellano PR. Cholesterol catabolism as a therapeutic target in Mycobacterium Tuberculosis. Trends Microbiol. 2011; 19(11):530-539. PubMed | Google Scholar

  11. Pandey AK, Sassetti CM. Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci. 2008; 105(11) 4376–4380. PubMed | Google Scholar

  12. Miner MD, Chang JC, Pandey AK, Sassetti CM, Sherman DR. Role of cholesterol in Mycobacterium TB infection. Indian J Exp Biol. 2009; 47(6):407–411. PubMed | Google Scholar

  13. Muñoz S, Rivas-Santiago B, Enciso JA. Mycobacterium tuberculosis entry into mast cells through cholesterol-rich membrane microdomains. Scand J Immunol. 2009; 70(3):256–263. PubMed | Google Scholar

  14. Schwarz M, Lund EG, Russell DW. Two 7α-hydroxylase enzymes in bile acid biosynthesis. Curr Opin Lipidol. 1998; 9(2):113–118. PubMed | Google Scholar

  15. Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, Cohen JC. Linkage between cholesterol 7a-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest. 1998; 101(6):1283–1291. PubMed | Google Scholar

  16. Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, et al. Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest. 2002; 110(1):109–117. PubMed | Google Scholar

  17. Hofman MK, Groenendijk M, Verkuijlen PJJH, Jonkers IJ, et al. Modulating effect of the A?278C promoter polymorphism in the cholesterol 7α-hydroxylase gene on serum lipid levels in normolipidaemic and hypertriglyceridaemic individuals. Eur J Hum Genet. 2004; 12(11):935–941. PubMed | Google Scholar

  18. Lambrinoudaki IV, Kaparos GI, Vlachou SA, Stamatelopoulos KS, Georgiopoulos GA, Sergentanis TN, Panoulis CP, Christodoulakos GE, Alexandrou AP, Kouskouni EE, Creatsa MG, Papamichael CM. CYP A-204C polymorphism is associated with subclinical atherosclerosis in postmenopausal women. Menopause. 2008; 15(6):1163-1168. PubMed | Google Scholar

  19. Hagiwara T, Kono S, Yin G, Toyomura K, Nagano J, et al. Genetic Polymorphism in Cytochrome P450 7A1 and Risk of Colorectal Cancer: The Fukuoka Colorectal Cancer Study. Cancer Res. 2005; 65(7):2979-2982. PubMed | Google Scholar

  20. Fu L, Zhao Y, Wu X, Liu H, Shi J, Lu J, Zhou B. CYP7A1 genotypes and haplotypes associated with hypertension in an obese Han Chinese population. Hypertens Res. 2011; 34 (6): 722–727. PubMed | Google Scholar

  21. El Baghdadi J, Orlova M, Alter A, Ranque B, Chentoui M, et al. An autosomal dominant major gene confers predisposition to pulmonary TB in adults. J Exp Med. 2006; 203(7):1679–1684. PubMed | Google Scholar

  22. Nakamoto K, Wang S, Jenison RD, Guo GL, Klaassen CD, YvonneWan YJ, Zhong X. Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene. BMC Genet. 2006; 7:29. PubMed | Google Scholar

  23. Kallmann FJ, Reisner D. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tuberc. 1943; 47:549-574. PubMed | Google Scholar

  24. Yim JJ, Selvaraj P. Genetic susceptibility in tuberculosis. Respirology. 2010; 15(2):241-256. PubMed | Google Scholar

  25. Lamsyah H, Rueda B, Baassi L, Elaouad R, Bottini N, Sadki K, Martin J. Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan population. Tissue Antigens. 2009; 74(3):228–232. PubMed | Google Scholar

  26. Sadki K, Lamsyah H, Rueda B, Akil E, Sadak A, Martin J, El Aouad R. Analysis of MIF, FCGR2A and FCGR3A gene polymorphisms with susceptibility to pulmonary tuberculosis in Moroccan population. J Genet Genomics. 2010; 37(4):257?264. PubMed | Google Scholar

  27. Arji N, Busson M, Iraqi G, Bourkadi JE, Benjouad A, Boukouaci W, et al. The MCP-1 (CCL2) -2518 GG genotype is associated with protection against pulmonary tuberculosis in Moroccan patients. J Infect Dev Ctries. 2012; 6(1):73-78. PubMed | Google Scholar

  28. Srivastava A, Choudhuri G, Mittal B. CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population. Metabolism. 2010; 59(6):767–773. PubMed | Google Scholar

  29. Cooper AD, Chen J, Botelho-Yetkinler MJ, Cao Y, Taniguchi T, Levy-Wilson B. Characterization of hepatic-specific regulatory elements in the promoter region of the human cholesterol 7 α-hydroxylase gene. J Biol Chem. 1997; 272(6):3444–3452. PubMed | Google Scholar

  30. Hegele RA, Wang J, Harris SB, Brunt JH, Young TK, et al. Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis. 2001; 154(3):579–587. PubMed | Google Scholar

  31. De Castros-Orós I, Pampin S, Cofán M, Mozas P, et al. Promoter variant - 204A > C of the cholesterol 7α-hydroxylase gene: Association with response to plant sterols in humans and increased transcriptional activity in transfected HepG2 cells. Clin Nutr. 2011; 30(2):239-246. PubMed | Google Scholar

  32. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell. 2000; 6(3):507-515. PubMed | Google Scholar

  33. Korf H, Beken SV, Romano M, Steffensen KR, Stijlemans B, et al. Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice. J Clin Invest. 2009; 119(6):1626 –1637. PubMed | Google Scholar

  34. Zhao C, Dahlman-Wright K. Liver X receptor in cholesterol metabolism. J Endocrinol. 2010; 204(3):233–240. PubMed | Google Scholar

  35. Grant AV, El Baghdadi J, Sabri A, El Azbaoui S, Alaoui-Tahiri K, Rhorfi IA, et al. Age-Dependent Association between Pulmonary Tuberculosis and Common TOX Variants in the 8q12–13 Linkage Region. American J of Hum Genet. 2013; 92(3):407–414. PubMed | Google Scholar